Phase II Study of Pegylated Liposomal Doxorubicin in Heavily Pretreated Epithelial Ovarian Cancer Patients (Q57903888)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2004

Language	Label	Description	Also known as
English	Phase II Study of Pegylated Liposomal Doxorubicin in Heavily Pretreated Epithelial Ovarian Cancer Patients	scientific article published on 01 January 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

0 references

Domenica Lorusso

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

Maria Gabriella Ferrandina

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Naldini A

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

Testa A

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

D'Agostino G

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

Scambia G

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

67

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

3-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

243-249

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

https://api.crossref.org/works/10.1159/000081324

21 January 2018

Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel

1 reference

https://api.crossref.org/works/10.1159/000081324

21 January 2018

Caelyx: phase II studies in ovarian cancer

1 reference

https://api.crossref.org/works/10.1159/000081324

21 January 2018

Relationship of dose intensity to the induction of palmar-plantar erythrodysesthia by pegylated liposomal doxorubicin in dogs

1 reference

https://api.crossref.org/works/10.1159/000081324

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1159/000081324

21 January 2018

Phase II study of liposomal doxorubicin in advanced gynecologic cancers

1 reference

https://api.crossref.org/works/10.1159/000081324

21 January 2018

Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum

1 reference

https://api.crossref.org/works/10.1159/000081324

21 January 2018

Multiple injections of pegylated liposomal Doxorubicin: pharmacokinetics and therapeutic activity.

1 reference

https://api.crossref.org/works/10.1159/000081324

21 January 2018

Identifiers

10.1159/000081324

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557785 AND SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57903888&oldid=2244827984"